)
)
For Medicare members, GLP-1s have been incredibly difficult to afford. The new Medicare GLP-1 Bridge program is helping change that.
$50/month copay for eligible GLP-1s, including Wegovy®, Zepbound® (KwikPen®), and the new oral pill Foundayo® (orforglipron)*^
Available to Medicare Part D members who meet certain BMI and health criteria*
Program runs July 1, 2026 – December 31, 2027^
*For eligible Medicare Part D patients with qualifying GLP-1 medication prescription for weight management. This information is not a guarantee of coverage. Actual eligibility will be determined by Medicare GLP-1 Bridge eligibility criteria. Copays will not qualify for deductible or out-of-pocket obligations.
^All medical services are provided through our affiliated medical group, WeightWatchers Clinic. Medications require eligibility and prescription. Not all will qualify.
What is the Medicare GLP-1 Bridge program and how does it work?
The Medicare GLP-1 Bridge program helps eligible Medicare members access weight-loss GLP-1 medications. The program starts July 1, 2026 and ends December 31, 2027. Those eligible for the program will get select GLP-1s for $50/month*^.
The Medicare GLP-1 Bridge program helps eligible Medicare members access weight-loss GLP-1 medications. The program starts July 1, 2026 and ends December 31, 2027. Those eligible for the program will get select GLP-1s for $50/month*^.
To qualify for the Medicare GLP-1 Bridge program, you must:
- Have Medicare Part D
- Meet specific BMI and health condition criteria that a doctor must document, mainly:
- BMI of 35 or higher, or
- BMI of 30-34.99 and have diastolic heart failure, uncontrolled high blood pressure, chronic kidney disease at stage 3a or higher, prediabetes, a previous heart attack or stroke, blocked arteries in your legs or arms with symptoms, or
- BMI of 30 or higher along with certain health conditions, including heart failure, uncontrolled high blood pressure, or chronic kidney disease, or
- BMI between 27-29.99 and have prediabetes, a previous heart attack or stroke, blocked arteries in your legs or arms with symptoms.
- You may not qualify if you:
- Already get GLP-1 drugs covered through your Medicare Part D plan.
- Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s).
Medication shown not representative of actual product, which is dispensed by a licensed pharmacy.
To qualify for the Medicare GLP-1 Bridge program, you must:
- Have Medicare Part D
- Meet specific BMI and health condition criteria that a doctor must document, mainly:
- BMI of 35 or higher, or
- BMI of 30-34.99 and have diastolic heart failure, uncontrolled high blood pressure, chronic kidney disease at stage 3a or higher, prediabetes, a previous heart attack or stroke, blocked arteries in your legs or arms with symptoms, or
- BMI of 30 or higher along with certain health conditions, including heart failure, uncontrolled high blood pressure, or chronic kidney disease, or
- BMI between 27-29.99 and have prediabetes, a previous heart attack or stroke, blocked arteries in your legs or arms with symptoms.
- You may not qualify if you:
- Already get GLP-1 drugs covered through your Medicare Part D plan.
- Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s).
Medication shown not representative of actual product, which is dispensed by a licensed pharmacy.
If you’re interested in participating, sign up for WW Med+ and our Clinicians will evaluate whether you meet the program's health requirements and submit a prior authorization request to Medicare. Once approved, you can pay $50 per month for Foundayo®, Wegovy® (injection and tablet formulations), and Zepbound® (KwikPen®)*^. The coverage for the medication is provided through the Medicare GLP-1 Bridge program and is separate from your Medicare Part D prescription drug benefit.
If you’re interested in participating, sign up for WW Med+ and our Clinicians will evaluate whether you meet the program's health requirements and submit a prior authorization request to Medicare. Once approved, you can pay $50 per month for Foundayo®, Wegovy® (injection and tablet formulations), and Zepbound® (KwikPen®)*^. The coverage for the medication is provided through the Medicare GLP-1 Bridge program and is separate from your Medicare Part D prescription drug benefit.
*For eligible Medicare Part D patients with qualifying GLP-1 medication prescription for weight management. This information is not a guarantee of coverage. Actual eligibility will be determined by Medicare GLP-1 Bridge eligibility criteria. Copays will not qualify for deductible or out-of-pocket obligations.
^All medical services are provided through our affiliated medical group, WeightWatchers Clinic. Medications require eligibility and prescription. Not all will qualify.
)
Why access meds from us? We give you support beyond the prescription.
Expert clinical care. With a focus on obesity care and weight management, WW Med+ Clinicians are experienced in evaluating eligibility for the Medicare GLP-1 Bridge program and helping members understand their treatment options.
Integrated lifestyle support. You’ll access WW’s proven weight-management tools, resources, and behavior-change support to help you build sustainable habits for long-term weight health.
Hassle-free everything. Your Care Team includes a board-certified Clinician, Insurance Coordinator for pre-authorizations through Medicare, and a Care Coordinator who deals with refills and paperwork. We manage the insurance and approvals on your behalf, so you can focus on your health goals.
Convenient virtual care. Connect with a Clinician from the comfort of your home—no office visit necessary.
Tracking made easier. Log your side effects and receive refill reminders through your Weight Watchers app.
All medical services are provided through our affiliated medical group, Weight Watchers Clinic. Medications require eligibility and prescription.
Medication shown not representative of actual product, which is dispensed by a licensed pharmacy.
Members lose 29% more weight with Med+
At 12 months, Med+ members prescribed a GLP-1 medication who engaged regularly with the GLP-1 Success Program lost 29.1% more body weight, on average, than those who did not engage in behavioral support*.
*Based on an internal analysis of 3,325 members who requested at least 1 GLP-1 medication refill through Weight Watchers Med+ and self-reported both a starting weight and weight at week 52. On average, members who logged in to the GLP-1 Success Program at least 4 days each week (n=376) lost 22.20% body weight, and members who never logged in to the app (n=2,949) lost 17.20% body weight in 52 weeks. Not a randomized, controlled clinical trial. Self-reported outcomes have not been independently verified. Individual results may vary.
)
Who is eligible for the
Medicare GLP-1 Bridge program?
To qualify, you must be 18, have Medicare Part D (prescription drug coverage) and meet the program’s clinical criteria:
A BMI of 35 or higher
A BMI of 30 or higher and one or more of the following conditions: a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension while on at least two blood pressure medications, or chronic kidney disease stage 3a or above
A BMI of 27 or higher and one or more of the following conditions a diagnosis of pre-diabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease
Those with type 2 diabetes, moderate to severe obstructive sleep apnea, or MASH (fatty liver disease) are ineligible for the Medicare GLP-1 Bridge program.
Our WW Med+ Clinicians can help determine if you’re eligible and complete Medicare’s prior approval process for you.
Medication shown not representative of actual product, which is dispensed by a licensed pharmacy.
I’m interested in the Medicare GLP-1 Bridge program - what’s next?
If you’re already a WW Med+ Member
Simply message your Care Team and let them know you’re on Medicare and want to check if you qualify for the Medicare GLP-1 Bridge program. Our team members are ready to assist.
If you’re not already a WW Med+ Member
The first step is to find out whether WW Med+ is a good fit for you. Take a quick online quiz to learn more about your eligibility and treatment options. Be sure to indicate that you're interested in using Medicare to pay for medication.
If you decide to enroll in Med+, you’ll meet with a Clinician who can evaluate whether you qualify for the Medicare GLP-1 Bridge program. If appropriate, they’ll guide you through the next steps by completing a review of your health history and submitting any required documentation. Ready to get started?
The Medicare GLP-1 Bridge program medication cost of $50 per month is separate from the WW Med+ subscription fee